Ironwood Pharmaceuticals Inc (IRWD) stock
IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3062% below fair value
$4.85+0.02 (+0.41%)
Close on Nov 16, 2026Market cap $801.41MP/E 6.3Yield –
Ironwood Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Ironwood Pharmaceuticals's total debt was $120.70M at Mar 31, 2022. For fiscal 2018 it was $100.54M, down 31.6% from the year before. The highest annual figure on record is $174.67M in fiscal 2013.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $100.54M | -31.6% |
| FY2017 | Dec 31, 2017 | $146.90M | +11.1% |
| FY2016 | Dec 31, 2016 | $132.25M | -0.5% |
| FY2015 | Dec 31, 2015 | $132.96M | -15.9% |
| FY2014 | Dec 31, 2014 | $158.15M | -9.5% |
| FY2013 | Dec 31, 2013 | $174.67M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2022 | Mar 31, 2022 | $120.70M | +33.9% |
| Q3 FY2021 | Sep 30, 2021 | $120.70M | +20.1% |
| Q2 FY2021 | Jun 30, 2021 | $120.70M | +11.2% |
| Q2 FY2019 | Jun 30, 2019 | $78.33M | -36.1% |
| Q1 FY2019 | Mar 31, 2019 | $90.14M | -33.3% |
| Q4 FY2018 | Dec 31, 2018 | $100.54M | -31.6% |
| Q3 FY2018 | Sep 30, 2018 | $108.59M | -17.9% |
| Q2 FY2018 | Jun 30, 2018 | $122.61M | -7.1% |
| Q1 FY2018 | Mar 31, 2018 | $135.22M | – |
| Q4 FY2017 | Dec 31, 2017 | $146.90M | – |
| Q4 FY2016 | Dec 31, 2016 | $132.25M | – |
| Q3 FY2016 | Sep 30, 2016 | $131.94M | – |
See a number that looks wrong?